Csenge Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-387
| Closed | -$276K | – | 733 |
|
|
2024
Q4 | $276K | Sell |
387
-76
| -16% | -$54.1K | 0.02% | 568 |
|
|
2024
Q3 | $470K | Buy |
463
+41
| +10% | +$41.6K | 0.02% | 435 |
|
|
2024
Q2 | $444K | Sell |
422
-27
| -6% | -$28.4K | 0.03% | 432 |
|
|
2024
Q1 | $432K | Buy |
449
+49
| +12% | +$47.2K | 0.02% | 467 |
|
|
2023
Q4 | $351K | Buy |
400
+107
| +37% | +$94K | 0.02% | 488 |
|
|
2023
Q3 | $241K | Buy |
+293
| New | +$241K | 0.02% | 540 |
|
|
2023
Q2 | – | Sell |
-264
| Closed | -$217K | – | 690 |
|
|
2023
Q1 | $217K | Sell |
264
-14
| -5% | -$11.5K | 0.02% | 539 |
|
|
2022
Q4 | $201K | Buy |
+278
| New | +$201K | 0.02% | 561 |
|
|
2022
Q2 | – | Sell |
-302
| Closed | -$211K | – | 654 |
|
|
2022
Q1 | $211K | Buy |
+302
| New | +$211K | 0.02% | 592 |
|
|
2021
Q1 | – | Sell |
-417
| Closed | -$201K | – | 516 |
|
|
2020
Q4 | $201K | Sell |
417
-774
| -65% | -$373K | 0.02% | 411 |
|
|
2020
Q3 | $693K | Buy |
1,191
+3
| +0.3% | +$1.75K | 0.1% | 172 |
|
|
2020
Q2 | $741K | Buy |
1,188
+546
| +85% | +$341K | 0.11% | 144 |
|
|
2020
Q1 | $313K | Buy |
+642
| New | +$313K | 0.08% | 207 |
|
|
2018
Q4 | – | Sell |
-3
| Closed | -$1K | – | 1184 |
|
|
2018
Q3 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 911 |
|